Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)
Saudi Arabia · Delayed Price · Currency is SAR 34.20
-0.10 (-0.29%)
Aug 13, 2026, 3:16 PM AST
TADAWUL:4017 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,100 | 3,090 | 2,791 | 2,327 | 2,012 | 1,965 | |
Revenue Growth | 4.41% | 10.73% | 19.95% | 15.62% | 2.43% | 14.53% |
Cost of Revenue | 2,553 | 2,386 | 2,092 | 1,710 | 1,412 | 1,327 |
Gross Profit | 547.11 | 703.89 | 699.04 | 616.68 | 600.35 | 637.82 |
Selling, General & Admin | 287.99 | 386.33 | 337.69 | 292.49 | 177.23 | 173.35 |
Amortization of Goodwill & Intangibles | - | - | - | - | 1.74 | 1.77 |
Other Operating Expenses | -11.49 | -14.86 | -11.19 | -21.14 | -12.36 | - |
Operating Expenses | 293.02 | 395.89 | 339.98 | 282.7 | 218.3 | 261.4 |
Operating Income | 254.09 | 308 | 359.06 | 333.98 | 382.05 | 376.41 |
Interest Expense | -46.08 | -48.85 | -95.67 | -122.15 | -55.94 | -34.79 |
Interest & Investment Income | 14.74 | 21.3 | 23.67 | 42.88 | 24.88 | 6.17 |
Other Non Operating Income (Expenses) | - | - | - | - | - | 17.55 |
EBT Excluding Unusual Items | 222.75 | 280.46 | 287.07 | 254.71 | 351 | 365.34 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.13 | - |
Pretax Income | 222.75 | 280.46 | 287.07 | 254.71 | 351.12 | 365.34 |
Income Tax Expense | 29.84 | 32.34 | 23.4 | 22.69 | 20.44 | 4.56 |
Earnings From Continuing Operations | 192.91 | 248.12 | 263.67 | 232.02 | 330.68 | 360.78 |
Minority Interest in Earnings | 39.29 | 42.06 | 23.88 | 47.58 | -4.37 | -26.5 |
Net Income | 232.2 | 290.18 | 287.55 | 279.6 | 326.32 | 334.28 |
Net Income to Common | 232.2 | 290.18 | 287.55 | 279.6 | 326.32 | 334.28 |
Net Income Growth | -27.82% | 0.92% | 2.85% | -14.32% | -2.38% | 64.53% |
Shares Outstanding (Basic) | 230 | 230 | 217 | 200 | 200 | 100 |
Shares Outstanding (Diluted) | 230 | 230 | 217 | 200 | 200 | 100 |
Shares Change | 0.17% | 5.90% | 8.59% | - | 100.00% | - |
EPS (Basic) | 1.01 | 1.26 | 1.32 | 1.40 | 1.63 | 3.34 |
EPS (Diluted) | 1.01 | 1.26 | 1.32 | 1.40 | 1.63 | 3.34 |
EPS Growth | -27.94% | -4.71% | -5.29% | -14.32% | -51.19% | 64.53% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 28.73 | -7.59 | -81.55 | 32.31 | -138.23 | 174.63 |
Free Cash Flow Per Share | 0.13 | -0.03 | -0.38 | 0.16 | -0.69 | 1.75 |
Dividend Per Share | - | 0.330 | 0.300 | - | - | - |
Dividend Growth | - | 10.00% | - | - | - | - |
Gross Margin | 17.65% | 22.78% | 25.05% | 26.50% | 29.83% | 32.46% |
Operating Margin | 8.20% | 9.97% | 12.87% | 14.35% | 18.98% | 19.16% |
Profit Margin | 7.49% | 9.39% | 10.30% | 12.02% | 16.21% | 17.02% |
Free Cash Flow Margin | 0.93% | -0.25% | -2.92% | 1.39% | -6.87% | 8.89% |
EBITDA | 380.28 | 423.67 | 460.52 | 428.55 | 451.31 | 437.29 |
EBITDA Margin | 12.26% | 13.71% | 16.50% | 18.42% | 22.43% | 22.26% |
D&A For EBITDA | 126.19 | 115.67 | 101.45 | 94.57 | 69.26 | 60.88 |
EBIT | 254.09 | 308 | 359.06 | 333.98 | 382.05 | 376.41 |
EBIT Margin | 8.20% | 9.97% | 12.87% | 14.35% | 18.98% | 19.16% |
Effective Tax Rate | 13.40% | 11.53% | 8.15% | 8.91% | 5.82% | 1.25% |
Advertising Expenses | - | 37.72 | 26.29 | 31.72 | 5.74 | 11.66 |